NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
07 September 2024
| Name: | ONCOSIL MEDICAL LTD (OSL) | ||||||
| ISIN: | AU000000OSL3 | ||||||
| Date of Listing: | 15 August 2005 | ||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This entity is currently listed and quoted on the Australian Securities Exchange.Legal Status: (updated monthly)
ACN: 113 824 141ABN: 89 113 824 141
Registration Date: 14 April 2005
Capital Gains Tax (CGT) Status: (updated at least quarterly)
To crystallise a capital gain or capital loss on your securities in this entity, you are able to sell your securities on-market in the normal manner. If you determine that the market in your securities is illiquid and you still wish to crystallise a capital gain or loss, kindly contact deListed at admin@delisted.com.au for suggestions as to how you might proceed.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| ONCOSIL MEDICAL LTD | 03/06/2013 | |
| NEURODISCOVERY LIMITED | 03/06/2013 |
Boardroom Pty Ltd
Level 8, 210 George Street, Sydney NSW 2000
Tel : +61 2 9290 9600 or 1300 737 760
Fax : +61 2 9279 0664 or 1300 653 459
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed from NeuroDiscovery Limited | 03/06/2013 |
name changed from NeuroDiscovery Limited | 03/06/2013 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 30/06/2023 | Otto Buttula | -5,307,693 | $0.012 | $63,678 |
| 04/11/2022 | Brian Leedman | 927,975 | $0.048 | $44,951 |
| 24/08/2021 | Martin Cross | 95,000 | $0.051 | $4,845 |
| 27/10/2020 | Christopher Roberts | 3,000,000 | $0.135 | $405,000 |
| 23/10/2020 | Martin Cross | 177,727 | $0.140 | $24,798 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Doug Cubbin | Non Exec Chairman | 07/08/2023 |
| Nigel Lange | Managing Director, CEO | 21/01/2021 |
| Nicholas Falzon | CFO | 23/08/2013 |
| Christian Dal Cin | CFO, Company Secretary | 01/06/2023 |
| Peter Hall | Non Exec Director | 01/10/2024 |
| Gabriel Liberatore | Non Exec Director | 14/07/2023 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Brian Leedman | Non Exec Director | 15/09/2022 | 29/11/2023 |
| Otto Buttula | Non Exec Director | 20/07/2021 | 31/08/2023 |
| Karl Pechmann | CFO | 31/03/2020 | 24/05/2023 |
| Ricky Sharma | Non Exec Director | 01/11/2021 | 02/03/2023 |
| Martin Cross | Independent Director | 28/02/2017 | 24/10/2022 |
| Christopher Roberts | Executive Chairman, Independent Director | 21/01/2016 | 19/10/2021 |
| Roger Aston | Non Exec Director, Non Exec Director | 28/03/2013 | 19/10/2021 |
| Michael Bassett | Non Exec Director | 10/12/2018 | 19/10/2021 |
| Daniel Kenny | Director, CEO | 05/01/2015 | 01/12/2020 |
| Tom Milicevic | CFO | 22/10/2015 | 27/09/2019 |
| Martin Rogers | Director | 03/04/2013 | 20/10/2016 |
| Lawrence Gozlan | Independent Director | 27/02/2014 | 04/05/2015 |
| Neil Frazer | Executive Director, CEO | 02/07/2013 | 28/11/2014 |
| David McAuliffe | Non Exec Director | 14/04/2005 | 13/09/2013 |
| Simon O'Loughlin | Non Exec Director | 14/03/2012 | 02/07/2013 |
| Bret Mattes | Non Exec Chairman | 12/12/2011 | 28/03/2013 |
| Neville Bassett | Non Exec Director | 06/08/2010 | 14/03/2012 |
| Kyle Haynes | Director | 07/10/2010 | 14/03/2012 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
